A purple and pink letter v on a white background.
December 31, 2019

NeoGraft® Featured in Haute Living

NeoGraft ® was recently featured in a Haute Beauty (by Haute Living) article alongside our customer Dr. Demetri Arnaoutakis of Dr. Demetri M.D. who is also an active member of the American Academy of Facial Plastic and Reconstructive Surgery. NeoGraft ® was named the gold standard for hair restoration in the title of this article.

Dr. Demetri answers many questions that patients frequently ask about hair restoration in this article. He begins by explaining the minimally invasive grafting procedure known as FUE , stating that, “it eliminates the concern for linear scarring because FUE harvests each individual hair follicle instead of removing a thin strip.” This is the method that NeoGraft ® uses. Dr. Demetri then explains how the procedure works, noting that “ this method gently removes individual follicles from the back of the head (the “donor area”) in their naturally occurring groupings of about 1-4 hairs. Next, the follicles are then artistically implanted in the areas of the scalp and hairline where balding has occurred. This helps to complement the facial structure and current hairline.

NeoGraft ® 2.0 is equipped with a pneumatic motor that delivers precise pressure control for automated extraction and implantation allowing for an optimized workflow. The intuitive touchscreen interface includes a real-time graft counter along with patient data management capabilities. Aside from the technical features of the device, NeoGraft ® is also supported by a comprehensive business development program , clinical training , marketing solutions , and even staffing support designed to help your practice grow in the business of hair restoration

Interested in reading the full article from Haute Beauty? Read it here: The Gold Standard in Hair Restoration According To Dr. Arnaoutakis

July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.
May 22, 2026
Skin cancer radiotherapy improves treatment precision and patient outcomes. Learn how dermatology clinics use it in modern care plans.